跳至主要内容
临床试验/NCT07574138
NCT07574138招募中不适用

Comparison of Beta Cell Functional Changes in Patients With Early-onset Type 2 Diabetes Mellitus and Those With Typical Onset

University Medical Center Ho Chi Minh City (UMC)1 个研究点 分布在 1 个国家目标入组 296 人开始时间: 2025年2月24日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
296
试验地点
1

研究概览

简要总结

  • Research objectives: Evaluate and compare the clinical and paraclinical characteristics, complications, as well as the changes in beta cell function and HbA1C levels between two patient groups over a one-year follow-up period.

+Research design: This is a prospective cohort study, monitoring patients at 3, 6, 9, and 12 months.

  • Study Population and Sample Size: The study is planned to be conducted on 296 Vietnamese patients (accounting for a 20% dropout rate) who are being examined at the University of Medicine and Pharmacy Hospital in Ho Chi Minh City.
  • Key Evaluation Indicators: The function of beta cells and insulin resistance status are measured through the indices of HOMA-B, HOMA-IR, fasting C-peptide levels, and HbA1C levels.
  • Time and location: The study will be conducted from February 2025 to February 2028 at the Endocrinology Clinic, University Medical Center Ho Chi Minh City.

详细描述

  1. Research Objectives
  • Objective 1: Comparison of clinical characteristics, paraclinical findings, and complications in two groups of patients with early-onset and typical-onset Type 2 Diabetes Mellitus at the University of Medicine and Pharmacy Hospital in Ho Chi Minh City.
  • Objective 2: Comparison of changes in beta cell function and related factors in patients with early-onset and typical-onset Type 2 Diabetes Mellitus during a one-year follow-up at the University of Medicine and Pharmacy in Ho Chi Minh City.
  • Objective 3: Comparison of HbA1C levels and related factors in patients with early-onset and typical-onset Type 2 Diabetes Mellitus during a one-year follow-up at the University of Medicine and Pharmacy Hospital in Ho Chi Minh City.
  1. Study Population and Research Methods
  • Research design: Prospective observational cohort study.

  • Time and location: Implementation from February 2025 to February 2028 at the Endocrinology Clinic - University Medical Center Ho Chi Minh City.

  • Sample size: A minimum of 246 patients is required (equally divided into 2 groups). To account for a 20% dropout rate, the study plans to initially enroll 296 patients.

  • Sampling criteria:

  • Early Onset Group:

  • Patient with early-onset Type 2 Diabetes Mellitus (onset age ≥ 40 years).

  • Duration of Type 2 Diabetes Mellitus diagnosis 10 years.

  • Common onset group: Diagnosed with Type 2 Diabetes Mellitus from the age of 40 and above.

  • Patient with type 2 diabetes mellitus typically onset (onset age ≥ 40 years).

  • Duration of Type 2 Diabetes Mellitus 10 years.

  • To control for confounding factors, the study employed a 1:1 matching based on disease duration ( 1 year, 1-5 years, 5- 10 years).

  • Exclusion criteria: Excluding cases of type 1 diabetes (based on antibodies and C-peptide), secondary diabetes (due to medication, pancreatic pathology, etc.), pregnant women, or patients with severe renal impairment (eGFR < 30).

  1. Data Collection Process and Research Variables
  • The patient was monitored over a 12-month period with assessment milestones at T0 (baseline), T3, T6, T9, and T12.
  • Clinical variables: Age, sex, BMI, waist-to-hip ratio, blood pressure, family history, smoking/alcohol consumption habits.
  • Complication variables: Coronary artery disease, cerebrovascular disease, peripheral artery disease, retinopathy, and renal parameters (urinary albumin, eGFR).
  • Treatment variables: Oral medication regimen (Metformin, Sulfonylureas, DPP-4 inhibitors, SGLT2 inhibitors...), dosage and insulin regimen.
  • Clinical variables: HbA1C, beta cell function (fasting C-peptide, HOMA-B, HOMA-IR).
  1. Data analysis methods

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • The patient is diagnosed with Type 2 Diabetes Mellitus according to the ADA 2024 criteria (Fasting Glucose ≥ 126 mg/dl, or Glucose after 2 hours of an Oral Glucose Tolerance Test ≥ 200 mg/dl, or HbA1C ≥ 6.5%, or with typical symptoms accompanied by any Glucose ≥ 200 mg/dl).
  • The duration of Type 2 Diabetes Mellitus does not exceed 10 years.
  • Classification by age of onset: Early onset group (< 40 years) and typical onset group (≥ 40 years).
  • At least 6 months without the need for insulin and no recorded episodes of diabetic ketoacidosis since the time of diagnosis.
  • For the early-onset group: Autoantibodies (Anti-GAD, ICA) are negative and fasting C-peptide levels are > 0.6 nmol/L.
  • The patient consents to participate in the study and signs the informed consent document.

排除标准

  • Pregnant women or patients with acute illnesses at the time of assessment.
  • The patient has been diagnosed with or exhibits characteristics suggestive of Type 1 Diabetes Mellitus (such as a history of ketoacidosis, C-peptide < 0.2 nmol/L).
  • Secondary diabetes mellitus due to pancreatic disorders (pancreatitis, pancreatic tumors, pancreatic resection), due to medications (glucocorticoids), or due to other endocrine disorders (Cushing's syndrome, hyperthyroidism, acromegaly).
  • Severe renal failure with an estimated glomerular filtration rate (eGFR) < 30 mL/min/1.73 m².
  • Use of medications that affect beta cell function or complications such as prolonged high-dose corticosteroids, immunosuppressive agents, or chemotherapy.
  • Not of Vietnamese ethnicity.
  • Non-compliance with treatment guidelines or failure to attend scheduled follow-up appointments.

研究者

发起方
University Medical Center Ho Chi Minh City (UMC)
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验